All stock lists
ASML Holding N.V. - New York Re (NASDAQ:ASML)
NL · Delayed Price · Currency is USD
Technology · Semiconductors
$1495.16-$1.96 (-0.13%)
Market cap
$576B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 15, 1995
Website
Insider Score
––Not scored
ASML Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From ASML’s reported statements · Q3 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $39.47B
- Net income
- $13.47B
- Net margin
- 34.1%
Leverage20 / 20
Little or no net debt.
- Total debt
- $1.96B
- Cash
- $8.03B
- Net debt / EBITDA
- -0.37x
Liquidity13 / 20
Covers near-term obligations, without much room.
- Current assets
- $37.03B
- Current liabilities
- $24.90B
- Current ratio
- 1.49
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $22.73B
- Free cash flow
- $21.14B
- FCF margin
- 53.6%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 383.1M
- Share growth (1y)
- -1.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ASML Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $11.66 B | $9.33 B | $8.77 B | $9.72 B | $7.52 B | $7.69 B |
| Revenue Growth (YoY) | 55.16 % | 21.25 % | 13.25 % | 4.92 % | 0.65 % | 23.21 % |
| Cost of Revenue | $4.96 B | $4.29 B | $4.12 B | $4.65 B | $3.64 B | $3.56 B |
| Gross Profit | $6.70 B | $5.04 B | $4.64 B | $5.07 B | $3.88 B | $4.13 B |
| SG&A Expense | $352.60 M | $302.70 M | $302.30 M | $375.20 M | $303.20 M | $298.70 M |
| R&D Expense | $1.17 B | $1.28 B | $1.18 B | $1.26 B | $1.11 B | $1.17 B |
| Operating Expenses | $1.53 B | $1.58 B | $1.49 B | $1.64 B | $1.41 B | $1.47 B |
| Operating Income | $5.17 B | $3.46 B | $3.16 B | $3.43 B | $2.47 B | $2.66 B |
| Pretax Income | $5.89 B | $3.53 B | $3.30 B | $3.46 B | $2.57 B | $2.78 B |
| Tax Provision | $925.00 M | $609.60 M | $546.60 M | $618.70 M | $442.20 M | $487.40 M |
| Net Income | $4.96 B | $2.92 B | $2.76 B | $2.84 B | $2.12 B | $2.29 B |
| EPS (Basic) | $12.95 | $7.59 | $7.15 | $7.35 | $5.49 | $5.90 |
| EPS (Diluted) | $12.93 | $7.58 | $7.15 | $7.34 | $5.48 | $5.90 |
| Shares Outstanding | 383.10 M | 384.50 M | 385.40 M | 386.50 M | 387.30 M | 388.20 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.